Trials / Withdrawn
WithdrawnNCT02412813
LEGION™ Revision Metal Hypersensitivity Study
A Prospective, Randomized, Multi-Center, Metal Hypersensitivity Study Comparing OXINIUM and Cobalt Chrome Femoral Components in Failed Total Knee Arthroplasty
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Smith & Nephew, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a prospective, randomized, multi-center, metal hypersensitivity study comparing OXINIUM and cobalt chrome femoral components in subjects with failed total knee arthroplasty (TKA).
Detailed description
A total of 230 subjects will be randomized (1:1) to receive either an OXINIUM or cobalt chrome femoral components as part of their LEGION revision procedure. The objective of this study is to assess a lower serum metal ion concentration level in at least one of the three major mLTTs (Co, Cr or Ni) over 5 years in subjects receiving OXINIUM versus Cobalt Chrome femoral components as part of the LEGION Revision Total Knee System.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LEGION OXINIUM | Investigational Group |
| DEVICE | LEGION Cobalt Chrome | Control Group |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2025-04-01
- Completion
- 2025-04-01
- First posted
- 2015-04-09
- Last updated
- 2016-03-09
Locations
3 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT02412813. Inclusion in this directory is not an endorsement.